In vitro and in vivo gene transfer by an optimized α-cyclodextrin conjugate with polyamidoamine dendrimer

被引:136
作者
Kihara, F [1 ]
Arima, H [1 ]
Tsutsumi, T [1 ]
Hirayama, F [1 ]
Uekama, K [1 ]
机构
[1] Kumamoto Univ, Fac Pharmaceut Sci, Kumamoto 8620973, Japan
关键词
D O I
10.1021/bc025613a
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of the present study is to optimize the structure of the polyamidoamine starburst dendrimer (dendrimer) conjugate with alpha-cyclodextrin (alpha-CDE conjugate) as a nonviral vector. alpha-CDE conjugates of dendrimer (generation 3, G3) with various average degrees of substitution (DS) of alpha-CyD of 1.1, 2.4, and 5.4 were prepared. alpha-CDE conjugates formed the complexes with pDNA, resulting in a change of the particle sizes of pDNA complexes, but the distinction of physicochemical properties among their vector/pDNA complexes was only very slight. The membrane-disruptive ability of alpha-CDE conjugates on liposomes encapsulating calcein and their cytotoxicity to NIH3T3 and HepG2 increased with an increase in the DS value of alpha-CyD. In vitro gene transfer activity of alpha-CDE conjugates in both NIH3T3 and HepG2 cells augmented as the charge ratio (vector/pDNA) increased, and the activity of alpha-CDE conjugate (DS 2.4) was the highest at higher charge ratios among dendrimer (G3), the three alpha-CDE conjugates, and TransFast. After intravenous administration of pDNA complexes in mice, alpha-CDE conjugate (DS 2.4) delivered pDNA more efficiently in spleen, liver, and kidney, compared with dendrimer and other alpha-CDE conjugates (DS 1.1 and 5.4). The potential use of alpha-CDE conjugate (G3, DS 2.4) could be expected as a nonviral vector in vitro and in vivo, and these data may be useful for design of alpha-CyD conjugates with other nonviral vectors.
引用
收藏
页码:342 / 350
页数:9
相关论文
共 41 条
[1]   Beta-cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence [J].
Abdou, S ;
Collomb, J ;
Sallas, F ;
Marsura, A ;
Finance, C .
ARCHIVES OF VIROLOGY, 1997, 142 (08) :1585-1602
[2]   Cyclodextrin derivatives in pharmaceutics [J].
Albers, E ;
Muller, BW .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1995, 12 (04) :311-337
[3]   Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins [J].
Arima, H ;
Kihara, F ;
Hirayama, F ;
Uekama, K .
BIOCONJUGATE CHEMISTRY, 2001, 12 (04) :476-484
[4]   Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase [J].
Chen, WY ;
Bailey, EC ;
McCune, SL ;
Dong, JY ;
Townes, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (11) :5798-5803
[5]   Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine [J].
Croyle, MA ;
Roessler, BJ ;
Hsu, CP ;
Sun, R ;
Amidon, GL .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1348-1355
[6]   Vehicles for oligonucleotide delivery to tumours [J].
Dass, CR .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (01) :3-27
[7]  
Di Ianni M, 1999, GENE THER, V6, P703
[8]   The influence of sodium glycocholate and other additives on the in vivo transfection of plasmid DNA in the lungs [J].
Freeman, DJ ;
Niven, RW .
PHARMACEUTICAL RESEARCH, 1996, 13 (02) :202-209
[9]   Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo [J].
Gaetano, C ;
Catalano, A ;
Palumbo, R ;
Illi, B ;
Orlando, G ;
Ventoruzzo, G ;
Serino, F ;
Capogrossi, MC .
GENE THERAPY, 2000, 7 (19) :1624-1630
[10]   New class of polymers for the delivery of macromolecular therapeutics [J].
Gonzalez, H ;
Hwang, SJ ;
Davis, ME .
BIOCONJUGATE CHEMISTRY, 1999, 10 (06) :1068-1074